Neumora Therapeutics annual shares outstanding
2022
2023
2024
2025
Neumora Therapeutics Shares Outstanding History (NMRA)
Neumora Therapeutics reported 174.3M shares outstanding at the end of fiscal 2025.
View full Neumora Therapeutics company overviewNeumora Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 174.3M | 12.6M | +7.76% |
| 2024 | 2024-12-31 | 161.7M | 2.9M | +1.81% |
| 2023 | 2023-12-31 | 158.8M | 126.2M | +387.04% |
| 2022 | 2022-12-31 | 32.6M | — | — |
Neumora Therapeutics quarterly shares outstanding
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 187.9M | 26.0M | +16.02% |
| Q1 2026 | 2026-03-31 | 185.3M | 23.5M | +14.55% |
| Q4 2025 | 2025-12-31 | 174.3M | 12.6M | +7.76% |
| Q3 2025 | 2025-09-30 | 167.1M | 5.5M | +3.42% |
| Q2 2025 | 2025-06-30 | 161.9M | 1.9M | +1.20% |
| Q1 2025 | 2025-03-31 | 161.7M | 2.2M | +1.39% |
| Q4 2024 | 2024-12-31 | 161.7M | 2.9M | +1.81% |
| Q3 2024 | 2024-09-30 | 161.6M | 8.9M | +5.80% |
| Q2 2024 | 2024-06-30 | 160.0M | — | — |
| Q1 2024 | 2024-03-31 | 159.5M | — | — |
| Q4 2023 | 2023-12-31 | 158.8M | 126.2M | +387.04% |
| Q3 2023 | 2023-09-30 | 152.7M | — | — |
| Q4 2022 | 2022-12-31 | 32.6M | — | — |
Neumora Therapeutics Share Buyback History
A share buyback, also called a stock repurchase, is when a company uses cash to buy its own shares. Neumora Therapeutics share buyback history shows the reported cash used for repurchases. Buybacks can reduce shares outstanding, but issuance, stock-based compensation, acquisitions, and stock splits can change the share count separately.
Neumora Therapeutics used $0 to repurchase common stock in fy 2024. Across the latest 4 reported fiscal years, total share repurchases were $491,000.
| Fiscal year | Period ended | Share repurchases |
|---|---|---|
| 2024 | 2024-12-31 | $0 |
| 2023 | 2023-12-31 | $491,000 |
| 2022 | 2022-12-31 | $0 |
| 2021 | 2021-12-31 | $0 |
TickerStat uses SEC-reported cash payments for common-stock repurchases. The amounts describe capital returned through buybacks; they are not a forecast or a measure of the number of shares retired.
Neumora Therapeutics shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Neumora Therapeutics's shares outstanding moved from 32.6M to 174.3M, a change of 141.6M. The latest reported quarter, Q2 2026, shows 187.9M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neumora Therapeutics source filings ↗